Stay updated on SAGE-217 in Essential Tremor Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Essential Tremor Clinical Trial page.

Latest updates to the SAGE-217 in Essential Tremor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe notice about lapse in government funding and NIH operating status has been removed from the page, and this does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe two screenshots show minor visual/layout updates with no changes to fundamental study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.1%

Stay in the know with updates to SAGE-217 in Essential Tremor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Essential Tremor Clinical Trial page.